| P50 | author | Kai Rothkamm | Q39034555 |
| P2093 | author name string | Thorsten Rieckmann | |
| | Adrian Münscher | |
| | Sabrina Christiansen | |
| | Fruzsina Gatzemeier | |
| P2860 | cites work | Radiation-Induced Oral Mucositis | Q33711362 |
| | Treatment of allergic rhinitis with ectoine containing nasal spray and eye drops in comparison with azelastine containing nasal spray and eye drops or with cromoglycic Acid containing nasal spray | Q33759064 |
| | DNA double-strand breaks induced by high NaCl occur predominantly in gene deserts | Q35651286 |
| | A biological approach to mucositis | Q35871694 |
| | Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation. | Q54475068 |
| | Lack of correlation of desiccation and radiation tolerance in microorganisms from diverse extreme environments tested under anoxic conditions. | Q55285388 |
| | Role of the Extremolytes Ectoine and Hydroxyectoine as Stress Protectants and Nutrients: Genetics, Phylogenomics, Biochemistry, and Structural Analysis. | Q55411691 |
| | Properties of compatible solutes in aqueous solution | Q82118342 |
| | Osmolyte effects: impact on the aqueous solution around charged and neutral spheres | Q86979326 |
| | Effectiveness, Tolerability, and Safety of Ectoine-Containing Mouthwash Versus Those of a Calcium Phosphate Mouthwash for the Treatment of Chemotherapy-Induced Oral Mucositis: A Prospective, Active-Controlled, Non-interventional Study | Q97675003 |
| | Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients | Q36102873 |
| | Repopulation of cancer cells during therapy: an important cause of treatment failure | Q36167592 |
| | Efficacy and tolerability of an ectoine mouth and throat spray compared with those of saline lozenges in the treatment of acute pharyngitis and/or laryngitis: a prospective, controlled, observational clinical trial | Q37153374 |
| | The multifunctional role of ectoine as a natural cell protectant | Q37240204 |
| | Reduction of neutrophilic lung inflammation by inhalation of the compatible solute ectoine: a randomized trial with elderly individuals | Q37361474 |
| | Prevention and treatment of oral mucositis in patients receiving chemotherapy | Q37605224 |
| | Influence of the Compatible Solute Ectoine on the Local Water Structure: Implications for the Binding of the Protein G5P to DNA. | Q38295380 |
| | Effect of tetrahydropyrimidine derivatives on protein-nucleic acids interaction. Type II restriction endonucleases as a model system | Q38327472 |
| | DNA damage foci: Meaning and significance. | Q38379038 |
| | p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors. | Q39029551 |
| | Tissue reactions to ionizing radiation-Oral mucosa | Q39029695 |
| | HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1. | Q39112878 |
| | HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity | Q39163509 |
| | Neutrons describe ectoine effects on water H-bonding and hydration around a soluble protein and a cell membrane | Q39488264 |
| | Compatible Solutes and Extreme Water Stress in Eukaryotic Micro-Organisms | Q39735054 |
| | Ectoine can enhance structural changes in DNA in vitro. | Q41242718 |
| | Ectoine from halophilic microorganisms induces the expression of hsp70 and hsp70B' in human keratinocytes modulating the proinflammatory response | Q42484513 |
| | Influence of osmotic stress on desiccation and irradiation tolerance of (hyper)-thermophilic microorganisms. | Q43028074 |
| | Ectoine protects DNA from damage by ionizing radiation. | Q45357186 |
| | Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis: a randomised, comparator-controlled, intra-individual double-blind, multi-center trial | Q45357875 |
| | DNA protection by ectoine from ionizing radiation: molecular mechanisms. | Q47885565 |
| | Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma. | Q49647576 |
| | Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis | Q50092092 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | head and neck cancer | Q1783924 |
| | head and neck carcinoma | Q18554836 |
| | neck cancer | Q18966654 |
| P304 | page(s) | 6594 | |
| P577 | publication date | 2019-04-29 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | The inflammation-reducing compatible solute ectoine does not impair the cytotoxic effect of ionizing radiation on head and neck cancer cells | |
| P478 | volume | 9 | |